ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

Hellman, Suit Awarded ASTRO’s Gold Medals

October 26, 1990

Cigarette Smokers Are Dying Of Lung Cancer More Often Than Of Heart Disease, Study Finds

August 30, 1991

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

CCOP Application Now Total 180 Plus

November 26, 1982